European Institute of Timidity

So the German Presidency of the European Union can go out in a blaze of glory: Not only has it rescued us from constitutional annihilation, but it apparently saved the European Institute of Technology, by pulling a face-saving €308 million in initial funding out of the hat earl …

Edinburgh Bioquarter attracts investors from the US

They may not be on the road to nation status yet, but the Scots continue to set themselves apart in the biotech business.

Reading List - The environment business

No company can ignore the environment. It isn't just that they live in it, but they have social responsibilities and legal obligations. Then there are the chances to make money. So it makes sense to check out another new report from the OECD, Business and the Environment.

Cambridge catches them young

It used to be that university professors set out to produce clones of themselves, more men (sic) who would go on to do research in a university. This has changed a lot in recent years, perhaps because more profs really that there is life elsewhere.

R&D spending up by 6.0% in 2006

The US government seems to have gone off spending money on R&D.

Do businesses really reject imported ideas?

It is almost obligatory to trot out the cliche about the "not invented here" (NIH) syndrome whenever writing about innovation.

The illiterate workforce: an effort to bridge the skills gap in Europe

Science|Business editor Richard L. Hudson has a few numbers that, if you care about Europe's future in technology markets, might make you choke on your coffee:

The cultural divide between business people and academic researchers

In the late 1980s, a popular self-help book appeared about the battle of the sexes: Men are from Mars and Women are from Venus.

Roll up the map - Asia wants your job

Yes, the message is coming loud and clear, and most recently from Demos on one side of the Atlantic and Microsoft on the other: watch out Europe, or Asia will overtake you.

Broken in biotech: the VC financing model doesn't work

2007 will be a bumper year for biotech initial public offerings, according to the Burrill report on the state of the global life sciences industry, published earlier this month.

The new European Research Council: science must trump politics

Angelika Niebler, chair of the European Parliament committee that created the popular new European Research Council, vows to protect its political independence.

Can pharma innovate fast enough to survive?

Tales of the premiums pharma is paying to snaffle up new drug assets are acquiring the status of urban myths. While the prices seem unbelievable they might just be true.

Memo to entrepreneurs: Stay flexible

It happens all the time: A few scientists or engineers – experts in, say, proteomics or polymers – start a company to commercialize their inventions, and then hit a wall. Customers don't want what the founders expected.

A passport for VCs

Why is there so little venture capital money available in Europe? For an answer, consider this modest little case study in financial engineering:

The story of the basmati rice patent battle

Within the potentially rich but still largely unexplored lore of intellectual property (we are still waiting for an Isaiah Berlin of the history of IP), I came across a case that should be of considerable interest to the readers of this blog.

Recurring themes in intellectual property

The universe of intellectual property is structured around a number of recurring themes.

New ways of running R&D

It must have been early in the 1990s when the then top honcho – can't remember his official title – in Kobe Steel waxed lyrical about his company's use of global R&D.

Patent reform: déjà vu all over again?

Is it because the patent process is not entirely broken that it appears so difficult to fix?

Copyrighting tribal tradition

Extension of the coverage of the copyright has been one of the dominant traits of the inexorable rise of intellectual property. It is usually discussed in the context of high-technologies and, more specifically, of computer software.

Patent infrastructure: an authorised view

For those of you, who were interested in patent process challenges as summarised in our recent blog, I would like to recommend an informative communication by the President of European Patent Office made to its Administrative Council last June.

India's intellectual property dilemma

In the past few years, India has become a new development success story. Its rise was brought spectacularly to the public attention with audacious and successful takeovers in the global steel industry. But there is much more to India's performance than steel, or textiles.

The MP3 imbroglio

When a few weeks ago I discussed the peculiar features of patent situation of MP3 and the general sense that the MP3 inventor, the Fraunhofer Society, and its licensee Thomson Electronics, left money on the table, I did not know that an astute player was already seeking to quanti …

IP in China: is the bad boy coming good?

Among IP experts, China has long had a reputation for being the "baddest of them all." This reputation is well deserved. International intellectual property, in all its forms, copyrights and patents, is subject to a plunder on a truly massive scale.

Intellectual property everywhere….

Let me let you in on a secret: when there is no obvious topic for my weekly blog, I scour the Web. I am in particular a fan of Google News, which, unlike other news sites, operates without human intervention.

Will peer-to-patents fly?

It looked and sounded like a very good idea.

Profile

myscience

Articles Posted: 0
Links Seeded: 71
Member Since: 2/2007Last Seen: 5/31/2007

myscience has not filled out a bio yet.

myscience's Friends

Recommendations

myscience is not offering any recommendations at this time.

Watchlist

Tags:

  • (none)

myscience's Feeds

Subscribe to myscience's content using the feeds below. Use RSS for your newsreader and JSS to insert onto your own blog:
  • Articles
  • Seeds

myscience's Groups

myscience is not a member of any groups.